Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
J Microbiol Biotechnol. 2011 Jun;21(6):582-9.
Bioconversion of timosaponin A-III (TA-III), one of the major steroidal saponins isolated from the rhizomes of Anemarrhenae asphodeloides Bunge (Liliaceae), was investigated in Saccharomyces cerevisiae. Five bioconversion products, denoted compounds 2-6, were obtained. Biotransformation metabolite 2 was a stereoisomer of TAIII with a specific isotype F-ring and beta-ranged CH3-21, which rarely occurs in nature. The structure of 2 was elucidated by extensive spectroscopic analysis (H-H COSY, HSQC, HMBC), as well as by high-resolution mass spectral analysis. The growth inhibitory activity of compounds 1-6 was assayed against four human cancer cell lines, HepG2, H-1299, HT-29, and HCT-116. Compounds 1 and 2 obviously inhibited the growth of the four types of cancer cells with IC50 values being less than 19 micrometer. A structure-activity relationship is discussed, and the spirostane-ring F in compounds 1 and 2 appears to be the critical bioactive moiety for the cell growth inhibitory property.
从百合科知母根茎中分离得到的主要甾体皂甙之一知母皂甙 A-III(TA-III)在酿酒酵母中进行了生物转化研究。得到了五个生物转化产物,分别表示为化合物 2-6。生物转化代谢产物 2 是 TAIII 的立体异构体,具有特定的 F 环和β范围的 CH3-21,这在自然界中很少见。通过广泛的光谱分析(H-H COSY、HSQC、HMBC)以及高分辨率质谱分析,确定了 2 的结构。对化合物 1-6 对四种人类癌细胞系 HepG2、H-1299、HT-29 和 HCT-116 的生长抑制活性进行了测定。化合物 1 和 2 明显抑制了四种类型的癌细胞的生长,IC50 值小于 19 微米。讨论了构效关系,化合物 1 和 2 中的螺甾烷环 F 似乎是细胞生长抑制特性的关键生物活性部分。